Search for: "BIOGEN INC."
Results 121 - 140
of 259
Sorted by Relevance
|
Sort by Date
20 Mar 2012, 10:44 am
Biogen, and the divided infringement cases of McKesson... [read post]
6 Oct 2015, 12:57 pm
The multiple sclerosis drug’s maker, Biogen Inc., raised its price an average of 16% a year throughout the decade—21 times in all.It is an example of drug companies’ unusual ability to boost prices beyond the inflation rate to drive their revenue, even when demand for the drugs doesn’t cooperate.Well, let’s leave aside the most obvious point here. [read post]
17 Sep 2017, 9:30 pm
Biogen v Medeva (1996)Luke McDonagh12. [read post]
10 Jun 2010, 3:58 am
(Patent Docs) Avonex (Interferon) – US: Biogen launches submarine patent against competing providers of Interferon-Beta products: Biogen Idec MA Inc. v. [read post]
28 Jun 2009, 2:11 pm
Tex. as good as any other district for that purpose.In In re Genentech Inc. and Biogen, Inc., No. [read post]
13 Aug 2019, 7:34 pm
” Biogen Idec, Inc. v. [read post]
8 Aug 2019, 10:00 am
Biogen, Inc., recently certified the following issue to the California Supreme Court: “Does section 16600 of the California Business and Professions Code void a contract by which a business is restrained from engaging in a lawful trade or business with another business? [read post]
5 Oct 2015, 2:00 pm
Biogen Idec, Inc., 28 F. [read post]
28 Jun 2021, 2:04 pm
Biogen MA Inc., Petitioner v. [read post]
11 May 2017, 8:48 am
” Biogen, 713 F.3d at 1095. [read post]
21 Apr 2009, 2:20 pm
We get some insightful additional information from a Dow Jones article, "Biogen Says Sixth MS Patient On Tysabri Gets Brain Infection": Tysabri - sold by the Cambridge, Mass., biotech [Biogen Idec Inc. [read post]
7 Feb 2017, 1:20 pm
From this January 25, 2017 article published by Reuters, "Possible liver injury added to label of Biogen MS drug", we get the news report about this new drug safety issue for Tecfidera: The prescribing label for Biogen Inc's big-selling oral multiple sclerosis drug Tecfidera has been updated to include a warning of potential liver injury that could require hospitalization, the company said on Wednesday. [read post]
16 Nov 2011, 7:48 am
Biogen Idec, Inc., No. [read post]
13 Aug 2020, 1:55 pm
Biogen, Inc., and ruled that non-compete provisions in business to business contracts were not per se invalid, but rather subject to a rule of reasonableness. [read post]
22 Jan 2010, 9:28 am
See Biogen, Inc. v. [read post]
1 Nov 2019, 6:02 am
Biogen insufficiency: Enablement over the entire scope of the claimLord Hoffman established in Biogen Inc v Medeva plc [1997] RPC 1, that a specification must enable the invention to be performed across the full scope of the claim. [read post]
22 Mar 2016, 6:12 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
29 Feb 2016, 11:27 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 84 [week ending on Sunday 21 February] – Domain Name Law and Practice | Unwired Planet v Huawei and Samsung | In memoriam of Justice Antonin Scalia | Celltrion Inc. v Biogen Idec Inc., F. [read post]
30 Aug 2013, 7:33 pm
” Biogen, Inc. v. [read post]
8 Apr 2009, 11:47 am
There will be a phased voluntary withdrawal of psoriasis drug Raptiva from the U.S. market due to its link to a brain infection.Raptiva has recently been associated with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal disease of the central nervous system.Authorities in Europe, where Raptiva is sold by Merck KGaA (MRCG.DE), recommended in February that the drug be suspended in light of the PML risk.The European Commission is expected to follow that… [read post]
